Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus.

Kottke, Timothy; Galivo, Feorillo; Wongthida, Phonphimon; Maria Diaz, Rosa; Thompson, Jill; Jevremovic, Dragan; Barber, Glen N; Hall, Geoff; Chester, John; Selby, Peter; Harrington, Kevin; Melcher, Alan; Vile, Richard G

Kottke, Timothy; Galivo, Feorillo; Wongthida, Phonphimon; Maria Diaz, Rosa; Thompson, Jill; Jevremovic, Dragan; Barber, Glen N; Hall, Geoff; Chester, John; Selby, Peter; Harrington, Kevin; Melcher, Alan; Vile, Richard G.

Afiliação

Kottke T; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Galivo F; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Wongthida P; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Maria Diaz R; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Thompson J; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Jevremovic D; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Barber GN; Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.
Hall G; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Chester J; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Selby P; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Harrington K; The Institute of Cancer Research, London, UK.
Melcher A; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
Vile RG; Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK

Mol Ther ; 16(7): 1217-1226, 2008 Jul.

Article em En | MEDLINE | ID: mdl-28178481

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google